Some experimental and clinical studies showed that treatment with heparin inhibits the development of ischemia/reperfusion-induced AP (14), ameliorates the severity of taurocholate-induced pancreatitis (15), and decreases the incidence of pancreatic encephalopathy (PE) (16).
Protective effect of low-molecular-weight heparin on pancreatic encephalopathy in severe acute pancreatic rats.